The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Companion DX
Polymorphisms in TPMT and TYMS may predict severe toxicity in DPYD wild-type patients receiving fluoropyrimidine (FP) chemotherapy for colorectal cancer.
 
Aine Mary Peoples
No Relationships to Disclose
 
Gul Ahmed
No Relationships to Disclose
 
Raimundas Galiauskas
No Relationships to Disclose
 
Roisin O Sullivan
No Relationships to Disclose
 
Patrick Forde
No Relationships to Disclose
 
Prateesh Varughese
No Relationships to Disclose
 
Pratheesh Sathyan
Employment - Companion DX
 
Elisabete Amaral-Trusty
Employment - Companion DX
 
Laura McGrath
Employment - Companion DX
 
Kevin P Rosenblatt
Employment - Companion DX
 
Mehdi Dehghani
Employment - Companion DX
 
Kristen C Floyd
Employment - Companion DX
 
Brian Richard Bird
Consulting or Advisory Role - Amgen; LEO Pharma; Merck; Novartis; Pfizer; Teva
Speakers' Bureau - Amgen; LEO Pharma; Merck; Novartis; Pfizer; Teva
Research Funding - Bayer; Novartis; Pfizer; Roche; Teva
Travel, Accommodations, Expenses - Bayer; Novartis; Pfizer; Roche; Teva
 
Conleth G. Murphy
Consulting or Advisory Role - Amgen; Astellas Pharma; Janssen; Pfizer
Travel, Accommodations, Expenses - Amgen; Roche